Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1953 1
1958 1
1961 1
1962 1
1963 1
1964 2
1965 2
1966 1
1968 3
1970 2
1971 2
1972 1
1973 1
1974 1
1975 2
1976 1
1977 5
1980 1
1983 1
1987 1
1988 1
1989 1
1990 1
1992 5
1993 4
1994 1
1995 1
1996 4
1997 2
1998 3
1999 2
2000 1
2001 5
2002 2
2003 4
2004 7
2005 2
2006 5
2007 9
2008 12
2009 19
2010 7
2011 21
2012 26
2013 42
2014 48
2015 73
2016 99
2017 112
2018 128
2019 124
2020 164
2021 207
2022 232
2023 239
2024 280
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,740 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity.
Long L, Wei J, Lim SA, Raynor JL, Shi H, Connelly JP, Wang H, Guy C, Xie B, Chapman NM, Fu G, Wang Y, Huang H, Su W, Saravia J, Risch I, Wang YD, Li Y, Niu M, Dhungana Y, Kc A, Zhou P, Vogel P, Yu J, Pruett-Miller SM, Peng J, Chi H. Long L, et al. Among authors: niu m. Nature. 2021 Dec;600(7888):308-313. doi: 10.1038/s41586-021-04109-7. Epub 2021 Nov 18. Nature. 2021. PMID: 34795452 Free PMC article.
Genotoxicity of Nanocarriers.
Luo T, Gao L, Chen X, Xu K, Niu M. Luo T, et al. Among authors: niu m. Curr Drug Metab. 2018;19(2):110-123. doi: 10.2174/1389200218666171031122346. Curr Drug Metab. 2018. PMID: 29086685 Review.
Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation.
Qiao X, Wu X, Chen S, Niu MM, Hua H, Zhang Y. Qiao X, et al. Among authors: niu mm. J Enzyme Inhib Med Chem. 2024 Dec;39(1):2295241. doi: 10.1080/14756366.2023.2295241. Epub 2023 Dec 22. J Enzyme Inhib Med Chem. 2024. PMID: 38134358 Free PMC article.
1,740 results